Q-Line Biotech IPO GMP Today
The Q-Line Biotech IPO GMP is ₹112 (+32.7% over the upper price band of ₹343) as of 29 May 2026, giving an estimated listing price of ₹455 per share. On a minimum application of 800 shares, that is an estimated gain of ₹89,600. GMP has fallen by ₹29 since tracking began on 20 May.
Last updated
- Issue Price
- ₹343
- GMP
- ₹112
- GMP %
- +32.7%
- Est. listing
- ₹455
- Est. gain / application
- +₹89,600
Q-Line Biotech IPO GMP trend
Tracked for 13 days. High ₹141 on 20 May, low ₹0 on 17 May.
Q-Line Biotech IPO GMP day-wise
| Date | GMP | Change | GMP % | Est. listing | Est. gain (800 sh) |
|---|---|---|---|---|---|
| (latest) | ₹112 | -₹17 | 32.65% | ₹455 | +₹89,600 |
| ₹129 | +₹5 | 37.61% | ₹472 | +₹1,03,200 | |
| ₹124 | +₹16 | 36.15% | ₹467 | +₹99,200 | |
| ₹108 | +₹7 | 31.49% | ₹451 | +₹86,400 | |
| ₹101 | -₹24 | 29.45% | ₹444 | +₹80,800 | |
| ₹125 | -₹2 | 36.44% | ₹468 | +₹1,00,000 | |
| ₹127 | 0 | 37.03% | ₹470 | +₹1,01,600 | |
| ₹127 | +₹10 | 37.03% | ₹470 | +₹1,01,600 | |
| ₹117 | +₹117 | 34.11% | ₹460 | +₹93,600 | |
| ₹0 | -₹69 | 0.00% | ₹343 | ₹0 | |
| ₹69 | -₹41 | 20.12% | ₹412 | +₹55,200 | |
| ₹110 | -₹31 | 32.07% | ₹453 | +₹88,000 | |
| ₹141 | — | 41.11% | ₹484 | +₹1,12,800 |
Est. listing = upper price band (₹343) + GMP. Est. gain = GMP × 800 shares (2 lots, the minimum application).
Q-Line Biotech IPO subscription status
| QIB | 123.94x |
|---|---|
| bNII | 178.82x |
| sNII | 81.35x |
| Retail | 71.44x |
| Total | 102.49x |
Reading the Q-Line Biotech IPO GMP
The grey market premium is the price above the issue price at which Q-Line Biotech IPO shares are informally traded before listing. A GMP of ₹112 on an upper band of ₹343 suggests the shares could open around ₹455, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand, and SME GMP in particular can swing sharply on low volumes. Check it together with the subscription numbers and the company's financials before applying.
Q-Line Biotech IPO GMP: FAQs
- What is Q-Line Biotech IPO GMP today?
- The latest grey market premium (GMP) for the Q-Line Biotech IPO is ₹112 as of 29 May 2026, which is 32.65% over the upper price band of ₹343.
- What is the expected listing price of Q-Line Biotech IPO?
- Based on the current GMP, the estimated listing price of Q-Line Biotech IPO is ₹455 per share (₹343 issue price + ₹112 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Q-Line Biotech IPO?
- The lot size is 400 shares. The minimum application is 2 lots (800 shares), which costs ₹2,74,400 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.